13F Holdings
中文EN

AHCO AdaptHealth Corp.

Services-Home Health Care Services · Nasdaq · SEC CIK 1725255 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.3%
TTM net income YoY-594.6%
TTM EPS YoY-632.1%
Revenue 3-yr CAGR0.3%
Net income 3-yr CAGR—

Margins

Gross margin15.9%
Operating margin-11.5%
Net margin-12.9%
FCF margin2.6%
EBITDA margin2.2%

Returns

ROE-28.6%
ROA-9.5%
ROIC (approx.)-8.9%
Asset turnover0.73x

Leverage & solvency

Liabilities / assets70.6%
Debt / equity1.54x
Current ratio1.13x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.42x
Accruals ratio-23.0%
Payout ratio—
Capex / revenue15.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.24B$3.26B$3.20B$2.97B$2.45B
Cost of revenue$2.64B$2.58B$2.58B$2.39B$2.01B
Gross profit$609.20M$681.09M$624.07M$580.12M$445.61M
SG&A expense$382.29M$359.24M$334.59M$324.81M$167.50M
Operating income$90.87M$263.73M-$598.40M$190.41M$225.60M
Interest expense$103.60M$124.70M$131.00M$112.40M$95.19M
Pretax income-$15.15M$136.02M-$723.78M$97.90M$190.96M
Income tax$50.88M$41.24M-$49.00M$24.77M$32.81M
Net income-$70.79M$90.42M-$678.89M$69.32M$156.18M
EBITDA$472.80M$629.07M-$215.62M$541.59M$483.66M
EPS (basic)-0.520.62-5.060.471.12
EPS (diluted)-0.520.61-5.310.330.67
Weighted avg. shares (diluted)135.15M135.53M134.42M138.99M133.03M
Balance sheet
Cash & equivalents$106.14M$109.75M$77.13M$46.27M$149.63M
Receivables$370.90M$408.02M$388.91M$359.15M$359.90M
Inventory$114.89M$139.84M$113.64M$127.75M$123.09M
Current assets$728.90M$755.79M$649.02M$585.31M$670.06M
PP&E, net$503.19M$474.56M$495.10M$487.08M$398.58M
Goodwill$2.46B$2.68B$2.72B$3.55B$3.51B
Intangibles$35.77M$105.55M$130.16M$162.77M$202.23M
Total assets$4.32B$4.49B$4.51B$5.22B$5.25B
Current liabilities$712.39M$566.99M$537.00M$456.21M$499.81M
Short-term debt$20.31M$16.25M$53.37M$35.00M$20.00M
Long-term debt$1.72B$1.96B$2.09B$2.15B$2.18B
Total debt$1.74B$1.98B$2.15B$2.19B$2.20B
Total liabilities$2.79B$2.91B$3.04B$3.06B$3.18B
Shareholders' equity$1.52B$1.57B$1.46B$2.15B$2.06B
Net debt$1.63B$1.87B$2.07B$2.14B$2.05B
Shares outstanding135.45M134.60M132.63M134.44M133.84M
Cash flow statement
Operating cash flow$601.77M$541.84M$480.67M$373.87M$275.68M
Capital expenditure$382.39M$306.06M$337.46M$391.42M$203.31M
Free cash flow$219.38M$235.78M$143.20M-$17.56M$72.37M
Investing cash flow-$303.19M-$310.27M-$357.28M-$411.17M-$1.82B
Financing cash flow-$302.19M-$198.95M-$92.53M-$66.05M$1.60B
Depreciation & amortization$381.93M$365.33M$382.78M$351.18M$258.05M
Stock-based compensation$21.88M$14.88M$22.47M$22.40M$25.32M
Share buybacks$0$0$29.27M$13.99M$0

Free plan shows the latest 5 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.